Stock Movers: Novo Nordisk Plunges, Beazley Gains on Takeover, Carlsberg's Cautious Outlook

Novo Nordisk Sales Forecast Shock

• 📉 Novo Nordisk shares plunged by 18% following a forecast of a steep 13% decline in sales for the year.
• ⚠️ This decline is attributed to intense price competition in the obesity drug market, pressure from the US government to lower drug prices, and competition from rivals like Eli Lilly and smaller companies offering cheaper versions.
• 💡 Despite the shock, the CEO expressed long-term optimism, highlighting the recent launch of their pill version and a focus on transforming and developing new products.

Beazley Agrees to Zurich Insurance Takeover

• 🤝 Beazley shares rose 8.4% after agreeing in principle to a sweetened £8 billion takeover offer from Zurich Insurance Group.
• 📈 This marks Zurich's sixth bid over the past year, with previous offers rejected for undervaluing the company.
• 💰 The agreed price represents a 60% premium to Beazley's closing price before the initial offer became public in January, a notably generous premium for a FTSE company.
• 🌍 The combined entity will have $15 billion in gross rates and premiums, with operations based in the UK, and this deal also boosted other companies in the sector like Hiscox and Zurich.

Carlsberg's Cautious Demand Outlook

• 🍺 Carlsberg shares increased by nearly 3% despite widening its operating profit outlook, reflecting a cautious stance on future demand for its drinks.
• 📊 The company expects organic growth of 2-6% in 2026, a slight increase from last year's 3-5% range, indicating concerns about changing consumer habits, a shift away from alcohol, rising prices, and tariffs.
• 🌎 The CEO warned that demand for beer in Western markets remains subdued and sees no immediate positive shift for the global consumer, though some growth is anticipated in premium and alcohol-free categories.
• 🔄 Carlsberg has been actively diversifying away from traditional beer products to mitigate these market challenges.